Latest filing published 18 Aug 2026 for Xtant Medical Holdings, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Filings by Abhinav Jain span 3 companies, the busiest being Aytu Biopharma, Inc, Talphera, Inc. and Xtant Medical Holdings, Inc. The record holds 11 filings, for trades running from 11 August 2023 to 15 August 2026.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The record was last updated on 18 August 2026 with a share grant in Xtant Medical Holdings, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations